Injectable Compounded Tirzepatide is a dual-action medication that combines GLP-1 and GIP receptor agonists, offering superior weight loss results compared to traditional GLP-1 medications
Dose escalation ended with an on-site visit before initiation of the first 5-week steady-state period
As we age, the natural production of these peptides declines, contributing to common signs of aging and slower recovery
Slows digestion GLP-1 medications delay digestion , slowing the movement of food as it travels from the stomach and into the small intestines
Boelaert JR, Weinberg GA, Weinberg ED
This effect appears to be driven by anti-inflammatory and proliferative mechanisms independent of receptor activation/signaling in the resident vascular cells [74,75,76]